Work

Supplementary Figures S1 through S4 from Optimizing the Sequence of Anti-EGFR–Targeted Therapy in EGFR-Mutant Lung Cancer

Year: 2023

Type: supplementary-materials

Abstract: Fig. S1: Schematic of derivation 'lineages' for drug-sensitive and -resistant cell lines used in this study Fig. S2: Characterization of T790M+ cell lines Fig. S3: Characterization of A+C-resistant cell lines Fig. S4: Characterization of AZD9291-resistant cell lines

DOI: 10.1158/1535-7163.22503663

Authors: Catherine B. Meador, Hailing Jin, Elisa de Stanchina, Caroline A. Nebhan, Valentina Pirazzoli, Lu Wang, Pengcheng Lu, Huy Vuong, Katherine E. Hutchinson, Peilin Jia, Xi Chen, Rosana Eisenberg, Marc Ladanyi, Katerina Politi, Zhongming Zhao, Christine M. Lovly, Darren A.E. Cross, William Pao

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362482011

Cites:

Cited by:

Related to: 10